European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia
about
Foetal and neonatal alloimmune thrombocytopaeniaAntenatal interventions for fetomaternal alloimmune thrombocytopeniaAntenatal interventions for fetomaternal alloimmune thrombocytopeniaCollaborative study to establish the first international standard for quantitation of anti-HPA-1a.Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism.Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1.The management of feto-maternal alloimmune thrombocytopenia: report of three cases.Advances in the management of alloimmune thrombocytopenia.Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusionReconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions.A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry.The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteersPredicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.Successful management of neonatal alloimmune thrombocytopenia in the second pregnancy: a case report.Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.Perinatal management of neonatal alloimmune thrombocytopenia associated with anti-group A antibody.Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune ThrombocytopeniaFetal and Neonatal Alloimmune Thrombocytopenia: Management and Outcome of a Large International Retrospective CohortContemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry.HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.Recent developments in fetal medicine.A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia.Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective.
P2860
Q21203031-DEDA6000-CB04-4E0F-80DE-0DE9AEA3B4A1Q24234535-59A5812E-DEA1-48B8-8262-2380B3C416EBQ24245104-5784B33D-8829-4AED-A7B2-E905A7254C9DQ33367845-74D858E7-A1E7-4DD5-9E4E-FDFE47080378Q33368580-D5B08574-AA03-4799-A9C4-1DA9DE68806CQ33369697-022E9000-3063-4A20-BB67-39B8000D3941Q33371168-2DB06A9E-36ED-4630-A32A-D1208D9C744CQ33372607-58DAF509-88C5-4EFF-A010-C50C1FA96392Q33373910-A81B3414-083D-4EAD-A649-E533394D2E82Q33380492-931F8303-87E9-424C-9129-96B45F8D1B78Q33390035-6BA71498-B31C-4D20-A9D4-5AC59A1BA768Q33392862-D70A8362-5FED-4AE0-87E3-8F6949E11AA8Q33395535-6A30FBB2-2D8C-4162-812C-66400041AF88Q33395614-B614BF1E-E212-4083-8437-322E91C4032CQ33405050-57E507DF-592D-4AD4-B04B-440B7BA24023Q33407495-5D613BC2-68F3-4420-92EA-C75CD5903154Q33407552-E91FCE7C-ECF3-4AB6-B8DC-0CB3E537E6AAQ33407728-00051D5F-46D8-473C-8812-D08CDF70F741Q33409227-EEEEE519-BA99-4EEC-AABB-1FB26206305EQ33411662-BA7787ED-E1E4-45DB-AFFA-D384041C9B68Q33414589-454A52C6-C218-4EE7-8903-A1496BFF5759Q33416091-7C6A4812-3577-480A-9FAA-A798AAE851C3Q33420991-2316D323-D520-4C4E-B96A-930AE74DC9A4Q33421975-02C6BD90-4BB3-4B08-932E-57D2D3734A0DQ33432924-1289072F-6D21-432D-A021-573857D6A3FFQ33435947-C5D6A56C-BC20-4623-B418-75AB157731E5Q33436491-003D5D4D-943C-47E1-A8AC-4C79B7961945Q33437901-60368B50-7323-45D6-87BF-129B467AD8A9Q33709509-A9F2826F-009E-43B3-B4DF-33F0733FD9B0Q37860397-73BB256A-3CA6-4C72-8619-857F775571DEQ42392796-68187527-815E-49B0-B288-8AF0B0D43C75
P2860
European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
European collaborative study o ...... al alloimmune thrombocytopenia
@ast
European collaborative study o ...... al alloimmune thrombocytopenia
@en
European collaborative study o ...... al alloimmune thrombocytopenia
@nl
type
label
European collaborative study o ...... al alloimmune thrombocytopenia
@ast
European collaborative study o ...... al alloimmune thrombocytopenia
@en
European collaborative study o ...... al alloimmune thrombocytopenia
@nl
prefLabel
European collaborative study o ...... al alloimmune thrombocytopenia
@ast
European collaborative study o ...... al alloimmune thrombocytopenia
@en
European collaborative study o ...... al alloimmune thrombocytopenia
@nl
P2093
P2860
P1476
European collaborative study o ...... al alloimmune thrombocytopenia
@en
P2093
Cecile Kaplan
Hartmut Kroll
Janet E Birchall
Michael F Murphy
P2860
P304
P356
10.1046/J.1365-2141.2003.04408.X
P407
P577
2003-07-01T00:00:00Z